CompoAtlas

Plant Calcium

Natural health product licensed in Canada

Licence holder
Atomy Canada Inc.
NPN or DIN-HM
80123028
Status
Active licence
Licence date
3 February 2023
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Calcium

Source : Lithothamnion corallioides - En entier

300 mg600,000 µg
Manganèse

Source : Produit de chélation de manganèse et d'acide aminé

0.9 mg1,800 µg
Manganèse

Source : Citrate de manganèse (II)

0.9 mg1,800 µg
Vitamine D

Source : Cholécalciférol

7.5 microgram15 µg
Magnésium

Source : Magnesium citrate, tribasic

150 mg300,000 µg
Magnésium

Source : Lithothamnion corallioides - En entier

150 mg300,000 µg
Magnésium

Source : Magnesium amino acid chelate

150 mg300,000 µg
Magnésium

Source : Oxyde de magnésium

150 mg300,000 µg
Vitamine K1

Source : Vitamine K1

17.5 microgram35 µg
Vitamine K2

Source : Ménaquinone 7

22.5 microgram45 µg
Cuivre

Source : Produit de chélation de cuivre (II) et de protéine végétale hydrolysée (PVH)

500 microgram1,000 µg
Cuivre

Source : Citrate de cuivre (II)

500 microgram1,000 µg
Bore

Source : Boron hydrolyzed vegetable protein (HVP) chelate

1.5 mgNot calculated
Bore

Source : Citrate de bore

1.5 mgNot calculated

Non-medicinal ingredients

Poly(dextrose), Cellulose microcristalline, Amidon de maïs, Croscarmellose de sodium, Dioxyde de silicium, Stéarate de magnésium, Maltodextrine, Hypromellose, Triglycérides à chaîne moyenne

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years2 Comprimé1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Calcium intake, when combined with sufficient Vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps (to) maintain/support immune function/system. Helps in connective tissue formation. Helps in the absorption (and use) of calcium and phosphorus. Helps to maintain healthy bones, hair, nail and/or skin. Helps to maintain the body's ability to metabolize nutrients. Helps to produce and repair connective tissue. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80123028

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line